Yes. The shortest answer is that the “Overcoming Resistance” report issued by CCA two years ago describes this all in great detail. I was one of the 10 co-authors of that report.
It would be a revenue guarantee. Canada would say that if you come to Canada, you will receive at least $13 million U.S. per year for this drug for making it practically available here. In the first year, maybe there are small sales. By year six, the projections are that the sales in Canada would exceed that number, so the revenue guarantee wouldn't cost the federal government any money whatsoever. It's a federal guarantee. The drug is still available and used in the provinces and territories, and it's paid for in the ordinary way that happens in those areas.
It's my understanding that the government is working now on a pilot to operationalize this, but the details of that are not known to me. It's been under way for some time, since the CCA report.